Toward Atomistic Modeling of Irreversible Covalent Inhibitor Binding Kinetics
The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
Covalent inhibitors have emerged as an important drug class in recent years, largely due to their many unique advantages as compared to noncovalent inhibitors, including longer duration of action, lower prolonged systemic exposure, higher potency, and selectivity. However, the potential off-target toxicity of covalent inhibitors, particularly of irreversible covalent inhibitors, represents a great challenge in covalent drug development. Therefore, accurate calculation of protein covalent inhibitor reaction kinetics to guide the design of selective inhibitors would greatly benefit covalent drug discovery efforts. In the present paper, we present a computational method to calculate the relative reaction kinetics between congeneric irreversible covalent inhibitors and their protein receptors. The method combines density functional theory calculations of the transition state barrier height of the rate-limiting step for reaction between the warhead of the inhibitor and a single protein residue, and molecular-mechanics-based free energy calculations to account for the interactions between the ligand in the transition state and the protein environment. The method was tested on four pharmaceutically interesting irreversible covalent binding systems involving 28 ligands; the mean unsigned error (MUE) of the relative reaction rate for all pairs of ligands between the predictions and experimental results for these tested systems is 0.79 log unit. This is to our knowledge the first time where the reaction kinetics of protein irreversible covalent inhibition have been directly calculated with physics-based free energy calculation methods and transition state theory. We anticipate the outstanding accuracy demonstrated here across a broad range of target classes will have a strong impact on the design of selective covalent inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Possible toxicity arising from protein haptenization is also a potential risk of covalent PPI inhibitors [133, 134].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [134]
Citations
Cites
Grimme, S., Antony, J., Ehrlich, S., & Krieg, H. (2010) · The Journal of Chemical Physics · doi:10.1063/1.3382344 · Cited by 59,686
Stephens, P. J., Devlin, F. J., Chabalowski, C. F., & Frisch, M. J. (1994) · The Journal of Physical Chemistry · doi:10.1021/j100096a001 · Cited by 23,248
An improved algorithm for reaction path following
Gonzalez, C., & Schlegel, H. B. (1989) · The Journal of Chemical Physics · doi:10.1063/1.456010 · Cited by 6,159
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., et al. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00864 · Cited by 3,047
Self-citationEfficient estimation of free energy differences from Monte Carlo data
Bennett, C. H. (1976) · Journal of Computational Physics · doi:10.1016/0021-9991(76)90078-4 · Cited by 2,755
Combining Synchronous Transit and Quasi‐Newton Methods to Find Transition States
Peng, C., & Bernhard Schlegel, H. (1993) · Israel Journal of Chemistry · doi:10.1002/ijch.199300051 · Cited by 2,076
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
Bochevarov, A. D., Harder, E., Hughes, T. F., Greenwood, J. R., Braden, D. A., Philipp, D. M., Rinaldo, D., Halls, M. D., Zhang, J., & Friesner, R. A. (2013) · International Journal of Quantum Chemistry · doi:10.1002/qua.24481 · Cited by 1,798
Self-citation
Research works printed but not linked: 4
- American Chemical Society International Historic Chemical Landmarks. Discovery and Development of Penicillin. http://www.acs.org/content/acs/en/education/whatischemistry/landmarks/flemingpenicillin.html (accessed Aug 30, 2015).
- Kuhn, 2017, Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors, J. Med. Chem., 60, 2485, 10.1021/acs.jmedchem.6b01881 · DOI · Paper page
- 2019, Schrodinger Suite 2019 Protein Preparation Wizard
- Mechoulam, 1986, The Pharmacohistory of Cannabis sativa
Cited by
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space
Lu, C., Wu, C., Ghoreishi, D., Chen, W., Wang, L., Damm, W., Ross, G. A., Dahlgren, M. K., Russell, E., Von Bargen, C. D., et al. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00302 · Cited by 2,005
Self-citationThe maximal and current accuracy of rigorous protein-ligand binding free energy calculations
Ross, G. A., Lu, C., Scarabelli, G., Albanese, S. K., Houang, E., Abel, R., Harder, E. D., & Wang, L. (2023) · Communications Chemistry · doi:10.1038/s42004-023-01019-9 · Cited by 178
Self-citationHahn, D., Bayly, C., Boby, M. L., Bruce Macdonald, H., Chodera, J., Gapsys, V., Mey, A., Mobley, D., Perez Benito, L., Schindler, C., et al. (2022) · Living Journal of Computational Molecular Science · doi:10.33011/livecoms.4.1.1497 · Cited by 84
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
“Possible toxicity arising from protein haptenization is also a potential risk of covalent PPI inhibitors [133, 134].”
BackgroundRecent Advances in Alchemical Binding Free Energy Calculations for Drug Discovery
Muegge, I., & Hu, Y. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00541 · Cited by 88
Quantum chemical package Jaguar: A survey of recent developments and unique features
Cao, Y., Balduf, T., Beachy, M. D., Bennett, M. C., Bochevarov, A. D., Chien, A. D., Dub, P. A., Dyall, K. G., Furness, J. W., Halls, M. D., et al. (2024) · The Journal of Chemical Physics · doi:10.1063/5.0213317 · Cited by 82
Self-citationMondal, D., & Warshel, A. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00782 · Cited by 66
Perspectives on Computational Enzyme Modeling: From Mechanisms to Design and Drug Development
Nam, K., Shao, Y., Major, D. T., & Wolf‐Watz, M. (2024) · ACS Omega · doi:10.1021/acsomega.3c09084 · Cited by 85
Δ-Quantum machine-learning for medicinal chemistry
Atz, K., Isert, C., Böcker, M. N. A., Jiménez-Luna, J., & Schneider, G. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp00834c · Cited by 72
Qian, R., Xue, J., Xu, Y. C., & Huang, J. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01024 · Cited by 52
The role of quantum chemistry in covalent inhibitor design
Mihalovits, L. M., Ferenczy, G. G., & Keserű, G. M. (2021) · International Journal of Quantum Chemistry · doi:10.1002/qua.26768 · Cited by 48
Affinity and Selectivity Assessment of Covalent Inhibitors by Free Energy Calculations
Mihalovits, L. M., Ferenczy, G. G., & Keserű, G. M. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00834 · Cited by 47
Bianco, G., Goodsell, D. S., & Forli, S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.10.005 · Cited by 44
“Highly computationally-intensive methods, such as hybrid MM/QM methods presented by Schmidt [57] and Yu [58] seek to characterize the entire process of binding and covalent attachment [52].”
MethodAwoonor‐Williams, E., & Rowley, C. N. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00897 · Cited by 41
Mechanistic aspects of thiol additions to Michael acceptors: Insights from computations
Roseli, R. B., Keto, A. B., & Krenske, E. H. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1636 · Cited by 32
Qiu, Y., O’Connor, M. S., Xue, M., Liu, B., & Huang, X. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00318 · Cited by 33
Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors
da Costa, C. H. S., Bonatto, V., dos Santos, A. M., Lameira, J., Leitão, A., & Montanari, C. A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00847 · Cited by 26
Zhou, J., Saha, A., Huang, Z., & Warshel, A. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00853 · Cited by 19
Mechanism-Based and Computational-Driven Covalent Drug Design
Luo, Y. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01278 · Cited by 23
Knight, J. L., Leswing, K., Bos, P. H., & Wang, L. (2021) · ACS symposium series · doi:10.1021/bk-2021-1397.ch008 · Cited by 18
Self-citationdos Santos, A. M., Oliveira, A. R. S., da Costa, C. H. S., Kenny, P. W., Montanari, C. A., Júnior, J. D. J. G. V., & Lameira, J. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00466 · Cited by 18
Hasan, M. N., Ray, M., & Saha, A. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c04710 · Cited by 17
Advanced technologies for screening and identifying covalent inhibitors
Guo, Y., Wen, S., Tong, A., & Wang, Y. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117833 · Cited by 12
Accurate Physics-Based Prediction of Binding Affinities of RNA- and DNA-Targeting Ligands
Abramyan, A. M., Bochicchio, A. M., Wu, C., Damm, W., Langley, D. R., Shivakumar, D. M., Lupyan, D., Wang, L., Harder, E. D., & Oloo, E. O. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01708 · Cited by 10
Self-citationMihalovits, L. M., Ferenczy, G., & Keserű, G. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.008 · Cited by 5
“We [19] and others [23-25] have shown that free energy changes and corresponding Ki and kinact values and the kinact/Ki ratio can be calculated with an accuracy useful in covalent inhibitor design.”
Danilack, A. D., Dickson, C. J., Soylu, C., Fortunato, M., Rodde, S., Münkler, H., Horn̆ák, V., & Duca, J. S. (2024) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-024-00560-6 · Cited by 9
“Reversible and irreversible forms of covalent inhibition are possible, both of which offer longer residence times than non-covalent inhibition [2, 3].”
Dynamics Playing a Key Role in the Covalent Binding of Inhibitors to Focal Adhesion Kinase
Liu, Y., Tan, J., Hu, S., Hussain, M., Qiao, C., Tu, Y., Lu, X., & Zhou, Y. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00418 · Cited by 7
Kinetic Modeling of Covalent Inhibition: Effects of Rapidly Fluctuating Intermediate States
Ghaby, K., & Roux, B. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00952 · Cited by 5
Levine, D. S., Jacobson, L. D., & Bochevarov, A. D. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00913 · Cited by 5
Self-citationOptimization of Covalent Warhead Trajectory for KRAS G12C Active-State Inhibition
Condakes, M. L., Civiello, R. L., Lakkaraju, S. K., Sloane, J. L., Chourb, L. S., Downes, D. P., Drexler, D. M., Dzhekieva, L., El-Samin, M., Levins, C. G., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03306 · Cited by 4
Alchemical Free Energy Workflows for the Computation of Protein-Ligand Binding Affinities
Herz, A. M., Kellici, T. F., Morao, I., & Michel, J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3449-3_11 · Cited by 4
Free Energy Calculations in Covalent Drug Design
Mihalovits, L. M., Ferenczy, G. G., & Keserű, G. M. (2024) · Wiley eBooks · doi:10.1002/9783527840748.ch23 · Cited by 4
Zeng, J., Yin, F., Fan, Y., Zheng, K., Zhang, Z., Liu, L. T., Jiang, R., Li, N., Liu, F., Xia, C., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118565 · Cited by 4
Wu, H., Zheng, J. W., Pang, H., Kao, Y.-C., Zalte, A. S., Abreu, C. R. A., Ibrahim, E. A., Biswas, S., Byun, C., Burns, J. W., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c10371 · Cited by 2
Awoonor‐Williams, E., & Rowley, C. N. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13132814 · Cited by 2
Computational support of structure-based targeted covalent inhibitor design
Abel, R., & Friesner, R. A. (2021) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2021.01.001 · Cited by 2
Self-citationOpen-source Δ-quantum machine learning for medicinal chemistryPreprint
Atz, K., Isert, C., Böcker, M. N. A., Jiménez-Luna, J., & Schneider, G. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-fz6v7
Δ-Quantum machine learning for medicinal chemistryPreprint
Atz, K., Isert, C., Böcker, M. N. A., Jiménez-Luna, J., & Schneider, G. (2021) · doi:10.33774/chemrxiv-2021-fz6v7-v2
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent Binders
Caravella, J. A., Toms, A. V., Sitnikov, N., Bartels, F., Svensson, R., Jacques-O’Hagan, S., Borthwick, J., Campos, S., Yin, Y., Zhao, X., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00328
Metadata
- Authors
- Yu, H. S., Gao, C., Lupyan, D., Wu, Y., Kimura, T., Wu, C., Jacobson, L., Harder, E., Abel, R., & Wang, L.
- Affiliations
- Schrodinger (United States) (US)
- Eli Lilly (United States) (US)
- Corresponding author
- Wang, Lingle
- ORCID
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-08-19
- Volume
- 59
- Issue
- 9
- Pages
- 3955-3967
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2969628133
- Cited by
- 39
- References
- 53
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 6
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Chemical Information and Modeling (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Physics and Astronomy › Atomic and Molecular Physics, and Optics › Advanced Chemical Physics Studies
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Keywords
- irreversible covalent inhibitors, relative reaction rates, free energy calculation, molecular mechanics, density functional theory, off-target toxicity, atomistic modeling
- MeSH terms
- Enzyme Inhibitors, Kinetics, Models, Molecular, Protein Binding, Proteins, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.